Welcome

HOPE Research Institute is an independent, multi-specialty, research organization dedicated to conducting clinical research trials in partnership with Valley physicians and their patients.

With NIH certified investigators and ACRP certified study coordinators, HOPE Research Institute can conduct inpatient and outpatient clinical trials across the Phoenix area.

HOPE Research Institute, LLC, conducts clinical research projects for the pharmaceutical industry in the Valley of the Sun, Phoenix, Arizona. Under the careful supervision of trained, experienced physicians, Valley residents can participate in studies of investigational products. HOPE's research facility is conveniently located in North Phoenix on Union Hills Drive near the intersection of freeways 51 and 101. Participants are placed into studies in a variety of therapeutic areas, depending on their eligibility. HOPE's therapeutic ares include: Family / Internal Medicine, Gastroenterology, Neurology / Sleep Medicine, Ophthalmology, Orthopedics / Orthopedic Surgery, Pain Management, Podiatry, Urology, or Women's Health. Study participation can be a positive experience for both the physician and the patient that may provide opportunities for learning, healthcare, and the betterment of our society.

Health and Clinical Research - Latest Headlines

Food and Drug Administration--Press Releases

FDA Advisory: Avoid Unintentional Exposure of Children and Pets to Evamist - 29 Jul 2010The U.S. Food and Drug Administration is warning that inadvertent exposure to Evamist through skin contact with patients using this product has the potential for adverse effects in children and pets.
FDA Approves Drug for Chronic Drooling in Children - 28 Jul 2010The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.
New Early Detection System Helps FDA Identify More than 100 Food Safety Problems in First 7 Months - 28 Jul 2010More than 100 food safety reports were submitted by industry to the U.S. Food and Drug Administration?s new electronic portal in its first months of operation, the agency said today.
Federal Agents Seize FastSize Extenders and FastSize EQM Erectile Quality Monitors - 27 Jul 2010At the request of the U.S. Food and Drug Administration, U.S. Marshals today seized $346,954.43 worth of FastSize Extender devices and FastSize EQM Erectile Quality Monitor devices, as well as component parts used in the manufacture of the FastSize Extender. The FastSize Extender and the FastSize EQM Erectile Quality Monitor are manufactured and distributed by FastSize, LLC of Aliso Viejo, Calif.
Pennsylvania Dairy Farm Agrees to Stop Improper Medication - 27 Jul 2010Owners agree to keep illegal drug residues out of animals sold for human consumption A Pennsylvania dairy farm has agreed to abide by federal regulations that protect meat from illegal drug residues caused by the unapproved medication of cattle before slaughter, as part of a consent decree of permanent injunction obtained by the U.S. Food and Drug Administration.

National Institutes of Health (NIH) News Releases

NIH Director Announces Appointment of Robert Kaplan as Associate Director for Behavioral and Social Sciences Research - 29 Jul 2010National Institutes of Health Director Francis S. Collins, M.D., Ph.D., announced today the appointment of Robert M. Kaplan, Ph.D., as Director, Office of Behavioral and Social Sciences Research (OBSSR) and NIH Associate Director for Behavioral and Social Sciences Research. Dr. Kaplan is expected to join the NIH in early 2011.
NIH-Funded Researchers Make Progress Toward Regenerating Tissue to Replace Joints - 29 Jul 2010A team of NIH-funded researchers has successfully regenerated rabbit joints using a cutting edge process to form the joint inside the body, or in vivo. Regenerative in vivo procedures are performed by stimulating previously irreparable organs or tissues to heal themselves. In this study, bioscaffolds, or three-dimensional structures made of biocompatible and biodegradable materials in the shape of the tissue, were infused with a protein to promote growth of the rabbit joint.
New Compound Improves Obesity-Related Health Complications in NIH-Led Study - 26 Jul 2010An experimental compound appears to improve metabolic abnormalities associated with obesity, according to a preliminary study led by researchers at the National Institutes of Health. A report of the study, which was conducted with obese mice, appears online today in the Journal of Clinical Investigation.
NIH Director Announces Appointment of Alan Guttmacher as Director of NICHD - 22 Jul 2010National Institutes of Health Director Francis S. Collins M.D., Ph.D., announced today the appointment of Alan E. Guttmacher, M.D., as director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), one of the 27 institutes and centers that comprise the National Institutes of Health. The appointment follows an extensive national search.

World Health Organization News

WHO and the International Olympic Committee sign agreement to improve healthy lifestyles - 21 Jul 201021 July 2010 -- In addition to promoting healthy lifestyle choices the agreement aims to support physical activity, sports for all, Tobacco Free Olympic Games, and the prevention of childhood obesity.
WHO announces new approaches to HIV prevention and treatment among children - 20 Jul 201020 July 2010 -- WHO has made new recommendations with the objective of reducing and eventually eliminating new HIV infections in children. To reduce the number of infants that are infected with HIV each year, WHO recommends that all women with HIV receive antiretroviral drugs to protect against transmission during pregnancy, delivery or breastfeeding.
More than five million people receiving HIV treatment - 19 Jul 201019 July 2010 -- WHO estimates that 1.2 million more people received HIV treatment in 2009 than in 2008. In addition HIV-related mortality can be reduced by 20% in the next five years if guidelines for early treatment are put into action.
International experts limit melamine levels in food - 06 Jul 20106 July 2010 -- The maximum amount of melamine allowed in powdered infant formula is 1 mg/kg according to new rulings from the UN's food standards body, Codex Alimentarius Commission. The Commission also issued new guidance for hygienic measures for safer fresh salads and seafood.